InvestorsHub Logo
Followers 42
Posts 5093
Boards Moderated 0
Alias Born 05/10/2012

Re: RobotMaster post# 1402

Monday, 04/15/2019 11:28:56 AM

Monday, April 15, 2019 11:28:56 AM

Post# of 7494
Mike Perry was the high up in Novartis's regenerative medicine arm, he needed permission to join the Avita Board of Directors, where he remained until FDA approval was very likely and close before he took over as CEO at Avita.

Novartis seems like a likely buyer. The IP would bolster their portfolio and they've already got an inside man.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News